ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · IEX Real-Time Price · USD
13.36
+0.31 (2.38%)
At close: Jul 19, 2024, 4:00 PM
13.50
+0.14 (1.05%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
ADMA Biologics Market Cap
ADMA Biologics has a market cap or net worth of $3.10 billion as of July 22, 2024. Its market cap has increased by 295.83% in one year.
Market Cap
3.10B
Enterprise Value
3.18B
1-Year Change
295.83%
Ranking
Category
Stock Price
$13.36
Market Cap Chart
Since October 17, 2013, ADMA Biologics's market cap has increased from $50.20M to $3.10B, an increase of 6,069.26%. That is a compound annual growth rate of 46.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 3.10B | 203.21% |
| Dec 29, 2023 | 1.02B | 33.78% |
| Dec 30, 2022 | 763.50M | 176.53% |
| Dec 31, 2021 | 276.10M | 49.73% |
| Dec 31, 2020 | 184.40M | -22.29% |
| Dec 31, 2019 | 237.30M | 114.17% |
| Dec 31, 2018 | 110.80M | -12.41% |
| Dec 29, 2017 | 126.50M | 91.67% |
| Dec 30, 2016 | 66.00M | -23.70% |
| Dec 31, 2015 | 86.50M | -16.67% |
| Dec 31, 2014 | 103.80M | 44.37% |
| Dec 31, 2013 | 71.90M | 43.23% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inari Medical | 3.19B |
| Amedisys | 3.19B |
| GoodRx Holdings | 3.19B |
| Biohaven Pharmaceutical Holding Company | 3.18B |
| Twist Bioscience | 3.14B |
| iRhythm Technologies | 3.08B |
| Oscar Health | 3.08B |
| Amicus Therapeutics | 3.07B |